SUBSCRIBE
SUBSCRIBE

Dicerna Pharmaceuticals

NEWS
Dicerna Pharmaceuticals was acquired by Novo Nordisk in December 2021.
Business
Boehringer Focuses on RNA
Boehringer has made a big push into RNA this month.
November 27, 2017
 · 
1 min read
 · 
Karl Thiel
Dicerna Could Pocket $201M in NASH R&D Deal With B
Business
Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim
Dicerna and Boehringer Ingelheim today announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics for the treatment of chronic liver diseases.
November 2, 2017
 · 
4 min read
 · 
Alex Keown
Policy
Sparring Over Trade Secrets, Dicerna Brings New Antitrust Suit Against Alnylam
August 11, 2017
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Alnylam Slaps Dicerna With Trade Secret Lawsuit
June 11, 2015
 · 
4 min read
Job Trends
Booming Dicerna Takes a Larger Space in Cambridge and Plans to Hire
February 26, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Tekmira Announces $24.5M Licensing And Collaboration Agreement With Dicerna Pharmaceuticals
November 17, 2014
 · 
2 min read
Load More
IN THE PRESS
Genetown
Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 01, 2021
July 1, 2021
 · 
4 min read
Drug Development
Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
June 22, 2021
 · 
8 min read
Genetown
Dicerna Announces Dosing Completion in Nedosiran PHYOX™4 Clinical Trial for Treatment of Primary Hyperoxaluria Type 3
June 16, 2021
 · 
9 min read
Genetown
Dicerna to Participate in 42nd Annual Goldman Sachs Global Healthcare Conference
June 3, 2021
 · 
3 min read
Genetown
Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug (IND) Application for LY3819469
May 27, 2021
 · 
7 min read
Business
Dicerna Announces Boehringer Ingelheim’s Acceptance of Candidate for Development Under RNAi Research Collaboration and License Agreement
May 24, 2021
 · 
7 min read
Genetown
Dicerna to Participate in Upcoming Investor Conferences - May 12, 2021
May 12, 2021
 · 
3 min read
Business
Dicerna Announces First Quarter 2021 Financial Results and Provides a Business Update
May 6, 2021
 · 
13 min read
Business
Dicerna to Report First Quarter 2021 Financial Results on May 6, 2021
April 29, 2021
 · 
2 min read
Business
Dicerna Sells OXLUMO™ (lumasiran) Royalty Interest to Royalty Pharma for Up to $240 Million
April 8, 2021
 · 
12 min read
Load More